ICON Group International

Introduction

Ever need a fact or quotation on ESP? Designed for speechwriters, journalists, writers, researchers, students, professors, teachers, historians, academics, scrapbookers, trivia buffs and word lovers, this is the largest book ever created for this single word. It represents a compilation from a variety of sources with a linguistic emphasis on anything relating to the term “ESP,” including non-conventional usage and alternative meanings which capture ambiguities. The entries cover all parts of speech (noun, verb, adverb or adjective usage) as well as use in modern slang, pop culture, social sciences (linguistics, history, geography, economics, sociology, political science), business, computer science, literature, law, medicine, psychology, mathematics, chemistry, physics, biology and other physical sciences. This “data dump” results in many unexpected examples for ESP, since the editorial decision to include or exclude terms is purely a linguistic process. The resulting entries are used under license or with permission, used under “fair use” conditions, used in agreement with the original authors, or are in the public domain. Proceeds from this book are used to expand the content and coverage of Webster’s Online Dictionary (www.websters-online-dictionary.org).

Excerpt

Nonfiction Usage

Script Usage

Do you believe in UFOs, astral projections, mental telepathy, ESP, clairvoyance, spirit photography, telekinetic movement, full trance mediums, the Loch Ness monster and the theory of Atlantis?–Dan Aykroyd and Harold Ramis. in Ghostbusters

Governmental Usage

Historical Economy in Spain. Exchange Rate Stability: On January 1, 1999, the peseta was fixed to the Euro at ESP 166.386 equals one Euro.

Patent Usage

5-ethyl-imidazotriazinones: Patented by Cristina Alonso-alija, Heike Gielen, Martin Hendrix, Ulrich Niewöhner, Dagmar Schauss, Hilmar Bischoff, Nils Burkhardt, Volker Geiss, Karl-Heinz Schlemmer, Nigel J. Cuthbert, Mary Fitzgerald, Richard G. Sturton and Martin Michels on May 21, 2002. Abstract: The invention relates to novel 5-Ethyl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases.

7-aminoimidazotriazones: Patented by Cristina Alonso-alija, Heike Gielen, Martin Michels, Dagmar Schauss, Hilmar Bischoff, Nils Burkhardt, Volker Geiss, Karl-Heinz Schlemmer, Nigel Cuthbert, Mary F. Fitzgerald, Graham Sturton and Ulrich Niewöhner on April 22, 2003. Abstract: The invention relates to novel 7-amino-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases.

Brake-pressure Control Device: Patented by Andreas Herp and Michael Schopper on July 11, 2003. Abstract: The invention relates to a brake-pressure control device with an ABS function and/or ESP function, whereby pump units (25, 25') provided for said functions also assume the function of a booster unit. According to said inventive brake-pressure control device, the amount of hydraulic medium guided to the slave units (15, 15') is determined simply by controlling the induction current control valve (27, 27').

Condensing optical system with corrected chromatic aberration, and information recording/reproducing apparatus using this optical system: Patented by Hiroshi Matsui and Osamu Koyama on May 5, 1991. Abstract: A condensing optical system for condensing light from a record medium onto a photodetector in such as an optical information recording/reproducing system, comprises a first lens group and a second lens group, and these first and second lens groups cooperate to correct aberrations, especially a chromatic aberration, in the system with respect to plural wavelengths of lights esp. by making Abbe's numbers of those first and second lens groups different from each other.

Cosmetic, Esp. Anti-Wrinkle Compositions Containing Water-Soluble or -Dispersible Lcst Polymers: Patented by Florence L'alloret on April 4, 2003. Abstract: The invention relates to the use of water-soluble or water-dispersible polymers comprising water-soluble or water-dispersible units and units with an LCST, the said units with an LCST having in water a demixing temperature of from 5 to 40°C at a mass concentration of 1%, as a tensioning agent in a cosmetic composition, especially an anti-wrinkle composition, and to the manufacture of a dermatological composition for smoothing out wrinkles and/or fine lines on the skin.

Flexible electrical submersible motor pump system for deviated wells: Patented by Brown L. Wilson on July 2, 1991. Abstract: Apparatus is provided to protect an electric submersible motor/pump (ESP) assembly as the normally rigid assembly is inserted into deviated or curved subterranean wells, i.e. directionally or horizontally drilled wells, which apparatus includes flexible joint connection means and cable protection devices.

Gels: Patented by Antony Perkins, Narinder Kehal, Neil Thompson, Philip J. Hammond and Rudolf R. Bukovnik on February 25, 1998. Abstract: Flame–retarded gels of oil–extended triblock copolymers are made with less than 40 % (pref. 35 %, 30 %) flame retardant additive while achieving at least 25 % (pref. 45 %, 65 %) reduction in burn rate under UL–94 Horizontal Burn Test. Preferred additives, e.g. char–forming and intumescent, esp. Phosphorous–containing, can achieve self–extinction of the test sample and non–ignition of cotton wool positioned 30 cm below the test sample (this being a modification of the above Test Method).

Imidazotriazinones Derivatives and Their Use against Inflammatory Processes And/or Immune Diseases: Patented by Cristina Alonso-alija, Heike Gielen, Martin Hendrix, Ulrich Niewöhner, Dagmar Schauss, Hilmar Bischoff, Nils Burkhardt, Volker Geiss, Karl-Heinz Schlemmer, Nigel J. Cuthbert, Mary Fitzgerald and Graham Sturton on May 17, 2002. Abstract: The invention relates to 7-(4-tert butyl-cyclohexyl)-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases.

ESP: Webster's Facts and Phrases